BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 8918614)

  • 21. Diabetic glomerulopathy in man and experimental animal models.
    Steffes MW; Mauer SM
    Int Rev Exp Pathol; 1984; 26():147-75. PubMed ID: 6400512
    [No Abstract]   [Full Text] [Related]  

  • 22. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.
    Aunapuu M; Pechter U; Arend A; Suuroja T; Ots M
    Medicina (Kaunas); 2003; 39(10):975-9. PubMed ID: 14578640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular cell proteoglycans: their possible role in progressive glomerular disease.
    Davies M
    Exp Nephrol; 1995; 3(2):122-6. PubMed ID: 7773631
    [No Abstract]   [Full Text] [Related]  

  • 25. Podocytes and the development of segmental glomerulosclerosis.
    Elger M; Kriz W
    Nephrol Dial Transplant; 1998 Jun; 13(6):1368-73. PubMed ID: 9641162
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrence of focal segmental sclerosis in children following renal transplantation.
    Striegel JE; Sibley RK; Fryd DS; Mauer SM
    Kidney Int Suppl; 1986 Jul; 19():S44-50. PubMed ID: 3528625
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypoplastic tubules occurring in diffuse mesangial sclerosis.
    Shimamura T; Weiss LS
    Pathol Int; 1996 Nov; 46(11):904-6. PubMed ID: 8970202
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible renal failure in focal glomerular sclerosis.
    Nagase S; Terasaki T; Sano M; Inage H; Koyama A; Narita M; Tojo S
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1197-203. PubMed ID: 3820831
    [No Abstract]   [Full Text] [Related]  

  • 29. The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage.
    Shirato I; Hosser H; Kimura K; Sakai T; Tomino Y; Kriz W
    Virchows Arch; 1996 Nov; 429(4-5):255-73. PubMed ID: 8972762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of nonimmune glomerulopathies.
    Kwoh C; Shannon MB; Miner JH; Shaw A
    Annu Rev Pathol; 2006; 1():349-74. PubMed ID: 18039119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glomerulosclerosis: pathogenetic mechanisms and possibility of regression].
    Faraggiana T; Giannakakis C
    G Ital Nefrol; 2008; 25 Suppl 44():S27-S32. PubMed ID: 19048583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Internephron heterogeneity of growth factors and sclerosis.
    Fogo A
    Kidney Int Suppl; 1994 Feb; 45():S24-6. PubMed ID: 8158892
    [No Abstract]   [Full Text] [Related]  

  • 34. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility.
    Kim JM; Wu H; Green G; Winkler CA; Kopp JB; Miner JH; Unanue ER; Shaw AS
    Science; 2003 May; 300(5623):1298-300. PubMed ID: 12764198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glomerular disease caused by solvents: an emerging problem].
    Bertelli G; Farina G; Alessio L
    Med Lav; 1982; 73(3):175-86. PubMed ID: 6752680
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal lesions of the FGS strain of mice: a spontaneous animal model of progressive glomerulosclerosis.
    Yoshida F; Matsuo S; Fujishima H; Kim HK; Tomita T
    Nephron; 1994; 66(3):317-25. PubMed ID: 8190185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The fate of podocytes in proteinuric nephropathies].
    Ortiz A; MarrĂ³n B; Ramos A
    Nefrologia; 2002; 22(5):425-31. PubMed ID: 12497743
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathways leading from glomerular injury to glomerulosclerosis.
    Schreiner GF
    Contrib Nephrol; 1990; 86():1-14; discussion 15-8. PubMed ID: 2078945
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic focal segmental glomerulosclerosis.
    Schnaper HW
    Semin Nephrol; 2003 Mar; 23(2):183-93. PubMed ID: 12704578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.